Matthew Szuhaj, Director, Consulting Strategy and Operations Practice, Deloitte (Biotech Location Guide 2008)
As the biotechnology industry matures beyond its R&D origins, first-generation biotech companies — like “Big Pharma” — before them, are facing important decisions about how to continue to develop products and establish production capacity to capitalize on the opportunities of a global marketplace.
